- SENSEXNIFTY 50
Pharma major Lupin's stock price has rallied 70 percent from the lows of March 2020. The company is scheduled to report its Q3FY21 earnings on Thursday (28 January). CNBC-TV18 expects the revenue to grow around 7 percent. Margins are expected to improve to 17 percent versus 11.4 percent on a year-on-year basis. Profit is likely to come in around Rs 300 crore.
CNBC-TV18's Ekta Batra has more details on key expectations from Lupin's third quarter or Q3FY21 results on Thursday.
Watch the video for more.
